Hay Fever News and Research

RSS

Hay fever (pollen allergy) is one of the most common kinds of allergies. About 35 million Americans suffer from hay fever. Pollen is made by trees, grasses, and weeds. During the spring, summer, and fall some plants release pollen into the air you breathe. Your symptoms might be different at different times of the year. It all depends on the kinds of plants that grow where you live and what allergies you have.

Specific test key to determine whether or not allergy symptoms are really allergy-related

Many people with allergy-like symptoms could get the test they need, and the right treatments for their symptoms, from their primary care physician if managed care practice guidelines encouraged the use of the test.

23 Mar 2005

Fathers' genes play an equal part in the spread of eczema

Doctors have known for many years that eczema - also known as atopic dermatitis - runs in families. In the past, it was thought that if a baby suffered from eczema, it was more likely to have come from the mother's side.

29 Nov 2004

Cells linked to asthma and eczema also help cure deadly illness in mice

Mast cells are immune cells known mostly for their unwanted effects: they cause the wheezing of asthma, the itching of eczema, the sneezing and runny nose of hay fever and, in extreme cases, the life-threatening shock of anaphylaxis.

20 Nov 2004

Mast cells can provide protection from a potentially deadly condition known as sepsis

14 Nov 2004

Some allergic conditions could increase your risk of suffering from blood cancer

Some allergic conditions could increase your risk of suffering from blood cancer as an adult, according to a new study published in the November 2004 issue of BMC Public Health. This is important news for the increasingly large numbers of allergy sufferers worldwide.

4 Nov 2004

Researchers identify a protein that could banish allergies

The suffering of millions of people with allergies could one day be eased thanks to new research from UK investigators. Findings from the University College London branch of the Ludwig Institute for Cancer Research (LICR), published in the Oct 2004 issue of Nature, detail how inactivating a key signalling molecule called p110delta reduced the effect of allergies on mice.

21 Oct 2004

Cutting levels of household allergens is unlikely to have much impact on childhood asthma

Cutting levels of household allergens, such as cat dander and dust mite, is unlikely to have much impact on the subsequent development of childhood asthma and respiratory allergies, suggests research in Thorax.

29 Sep 2004

Ranbaxy receives FDA approval to market Loratadine and Pseudoephedrine Sulfate extended release tablets

Ranbaxy Pharmaceuticals, a wholly-owned subsidiary of Ranbaxy Laboratories Limited of New Delhi, India, announced today that RLL has received approval from the U. S. Food and Drug Administration to manufacture and market Loratadine and Pseudoephedrine Sulfate Extended Release Tablets

26 Sep 2004

Asthma stable, allergies rising in British children

The rate of asthma among children in the United Kingdom seems to have stabilised, but the tendency for children to develop allergies is still increasing, according to a study in this week's BMJ.

26 Aug 2004

FDA approves revised labeling for anti-inflammatory corticosteroid nasal spray

AstraZeneca has announced that the U.S. Food and Drug Administration has approved revised labeling for its anti-inflammatory corticosteroid nasal spray RHINOCORT AQUA® (budesonide).

26 Aug 2004

Nasal cream effective in reducing the symptoms of allergic rhinitis

A nasal cream applied to the inside of the nose appears effective in reducing the symptoms of allergic rhinitis, according to an article in the August issue of The Archives of Otolaryngology – Head & Neck Surgery.

16 Aug 2004

Ways to economically recover recombinant proteins from transgenic tobacco

The economics of producing biopharmaceuticals from transgenic plants such as tobacco is still a roadblock to producing large quantities of urgently needed medicines, especially for people in underdeveloped nations.

12 Aug 2004

Health Canada is advising consumers not to use products containing Aristolochic Acid

Health Canada is advising consumers not to use products containing Aristolochic Acid, a naturally occurring toxin that can cause cancer, mutations in human cells, and end-stage kidney failure.

29 Jul 2004

Research into hay fever and temperature of the nose rises helps determine how reliable and effective anti-allergic agents are

In an attack of hay fever, the temperature of the nose rises. Effective medication prevents this too. An infrared camera provides non-contact images of the changes. Researchers can use these images to determine how reliable and effective anti-allergic agents are.

8 Jul 2004

Oral allergy syndrome, allergic response from fruit

For some of the nation's 35.9 million hay fever sufferers enjoying one of summer's fresh peaches or a juicy tomato may cause additional discomfort.

25 Jun 2004

All Black urges allergy sufferers to play it safe

All Black Kees Meeuws is fronting an Allergy New Zealand poster campaign urging allergy sufferers to play it safe and protect a life as part of Allergy Awareness Week, which kicks off May 10, 2004. The poster sports a bare-chested and tattooed Kees with his six-week-old daughter, Inéz (who is now three months old).

10 May 2004

Quality of dietary fat is associated with allergies

The quality of dietary fat is associated with the risk of hay fever and allergic sensitisation, but not atopic eczema and bronchial hyperreactivity.

27 Apr 2004

Allergies cost UK £1 billion per annum

Researchers from the Universities of Edinburgh and Aberdeen and St George’s Medical School in London say one in five children and adults in Britain suffer from allergies, with annual health services treatment bill running at £1billion. They call for more allergy specialists to meet the increased demand.

13 Apr 2004

Household molds trigger allergic rhinitis

April showers can increase the amount of mold found inside and outside the home. Along with pollens from trees, grasses, and weeds, molds are an important trigger of allergic rhinitis, affecting nearly 40 million Americans, according to the American Academy of Allergy, Asthma & Immunology (AAAAI).

12 Apr 2004

Olopatadine nasal spray shown to minimise hay fever

Alcon announced today results from a Phase III clinical trial demonstrating that olopatadine nasal spray, a nasal formulation of its market leading ophthalmic anti-allergy product, Patanol(R) ophthalmic solution, reduced seasonal allergic rhinitis (SAR) symptoms compared to placebo.

22 Mar 2004